Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Gastric Acid Hypersecretion
NCT00079833Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of esomeprazole in Zollinger–Ellison syndrome (ZES), sponsored by AstraZeneca. Started Nov 2003; status: completed.
02
Drugs
esomeprazole
03
Conditions
Zollinger–Ellison syndrome (ZES)
Beyond the preview
Go deeper on NCT00079833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079833.